The Global Liquid Biopsy Market size is expected to grow from USD 1.59 billion in 2022 to USD 7.02 billion by 2030, at a CAGR of 20.4% during the forecast period (2023-2030).
A liquid biopsy is a simple and non-invasive alternative to surgical biopsies that allows doctors to learn about tumors from a simple blood sample. In 1994, scientists advanced to the point where they could detect specific mutations in cfDNA. Dennis Lo discovered fetal cfDNA in the blood in 1997, and Veridex released the first commercially available liquid biopsy assay, the CELL SEARCH CTC test, in 2000. The FDA approved the first liquid biopsy test, the Cobas EGFR Mutation Test, as a cfDNA test for the EGFR gene mutation in lung cancer patients' blood in June 2016.
Revolutionize Your Strategy with Our Free Sample Report! Purchase Our Market Research Report and Unlock Six Months of After-Sale Support. Maximize Your Success with Premium Insights and Ongoing Support
https://introspectivemarketresearch.com/request/16300
Some of the key players in Liquid Biopsy Market include:
F. Hoffmann-La Roche Ltd. (Switzerland),Myriad Genetics Inc. (US),QIAGEN N.V. (Netherlands),Thermo Fisher Scientific Inc. (the US),Guardant Health Inc. (the US),BIOCEPT Inc. (the US),Illumina Inc. (the US),Angle plc (UK),Oncimmune(UK),Lucence health Inc. (US),FreenomeHoldings Inc. (US) and Other Major Players.
Unlock a treasure trove of market insights this Black Friday! Enjoy a spine-tingling Up to 30% off on our comprehensive market reports. Hurry up, offer valid for limited period Only.
The latest research on the Liquid Biopsy Market provides a comprehensive overview of the market for the years 2023 to 2030. It gives a comprehensive picture of the global Liquid Biopsy Market industry, considering all significant industry trends, market dynamics, competitive landscape, and market analysis tools such as Porter's five forces analysis, Industry Value chain analysis, and PESTEL analysis of the Liquid Biopsy Market. Moreover, the report includes significant chapters such as Patent Analysis, Regulatory Framework, Technology Roadmap, BCG Matrix, Heat Map Analysis, Price Trend Analysis, and Investment Analysis which help to understand the market direction and movement in the current and upcoming years. The report is designed to help readers find information and make decisions that will help them grow their businesses. The study is written with a specific goal in mind: to give business insights and consultancy to help customers make smart business decisions and achieve long-term success in their particular market areas.
Get Discount on Full Report of Liquid Biopsy Market:
https://introspectivemarketresearch.com/discount/16300
Segmentation Analysis of Liquid Biopsy Market:
By Cancer Type
· Lung
· Breast
· Liver
· Others
By Circulating Biomarker
· Circulating Tumor DNA
· Circulating Tumor Cells
· Others
By End-User
· Hospitals
· Laboratories
· Government Research Centre
Region and Country level Analysis:
· North America (U.S., Canada, Mexico)
· Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
· Western Europe (Germany, U.K., France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
· Asia-Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)
· Middle East & Africa (Turkey, Saudi Arabia, Bahrain, Kuwait, Qatar, UAE, Israel, South Africa)
· South America (Brazil, Argentina, Rest of SA)
https://introspectivemarketresearch.com/inquiry/16300
Liquid Biopsy Market Report Scope
| Details | |
| Market size value in 2021 | USD 1.59 Bn. |
| Revenue forecast in 2028 | USD 7.02 Bn. |
| Growth rate | CAGR of 20.4 % |
| Base year for estimation | 2022 |
| Actual estimates/Historical data | 2016 - 2021 |
| Forecast period | 2023 - 2030 |
https://introspectivemarketresearch.com/checkout/?user=1&_sid=16300
Table of Content:
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
Chapter 4: Market Landscape
Chapter 5: Liquid Biopsy Market by Cancer Type
Chapter 6: Liquid Biopsy Market by Circulating Biomarker
Chapter 7: Liquid Biopsy Market by End-User
Chapter 8: Company Profiles and Competitive Analysis
Chapter 9: Global Liquid Biopsy Market Analysis, Insights and Forecast, 2016-2028
Chapter 10: North America Liquid Biopsy Market Analysis, Insights and Forecast, 2016-2028
Chapter 11: Europe Liquid Biopsy Market Analysis, Insights and Forecast, 2016-2028
Chapter 12: Asia-Pacific Liquid Biopsy Market Analysis, Insights and Forecast, 2016-2028
Chapter 13: Middle East & Africa Liquid Biopsy Market Analysis, Insights and Forecast, 2016-2028
Chapter 14: South America Liquid Biopsy Market Analysis, Insights and Forecast, 2016-2028
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Read Related PR:
https://introspectivemarketresearch.com/reports/interstitial-lung-disease-treatment-market/
https://introspectivemarketresearch.com/reports/liver-cancer-diagnostics-market/
https://introspectivemarketresearch.com/reports/global-plant-based-beverages-market/
Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.
Contact us:
Introspective Market Research
3001 S King Drive,
Chicago, Illinois
60616 USA
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek